Leukemia and Lymphoma

The AJMC® Leukemia & Lymphoma compendium is a comprehensive resource for clinical news and expert insights for the blood cancers and their treatments.

AACR Progress Report Highlights New Drugs Along With Disparities, Challenges of Obesity, Aging Population

September 23rd 2022, 2:51pm


The annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances. Cancers related to obesity are also on the rise.

Nutrition Assistance No Guarantee Against Food Insecurity for Families Fighting Cancer

September 20th 2022, 1:36pm


A recent study showed that receiving Supplemental Nutrition Assistance Program benefits was not enough to address food insecurity among families whose children were fighting acute lymphoblastic leukemia.

Recent NCCN Update Moves Zanubrutinib Ahead of Ibrutinib in CLL/SLL Based on Toxicity Profile

September 11th 2022, 3:04pm


The National Comprehensive Cancer Network recommendations come as the FDA weighs an indication in chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) for zanubrutinib.

US Cutaneous T-Cell Lymphoma Incidence Increased From 2000 to 2018

September 8th 2022, 1:13pm


The findings, which contradict prior North American studies, suggest that the incidence rate of the rare cancer continues to increase in the United States.

TKI Therapy for Chronic-Phase CML Leads to Comparable Outcomes for AYAs and Older Adults

August 28th 2022, 12:30pm


A retrospective study found that adolescents and young adults (AYA) receiving tyrosine kinase inhibitors (TKI) therapy for chronic-phase chronic myeloid leukemia (CML) had similar prognoses to older patients despite also showing higher tumor burden at diagnosis.

Researchers Offer Guidance on Choosing Appropriate BTK Inhibitor in CLL

August 25th 2022, 4:20pm


Offering an effective, tolerable, and chemotherapy-free option for patients with chronic lymphocytic leukemia (CLL), Bruton’s tyrosine kinase (BTK) inhibitors have drastically changed the disease’s landscape.

Prophylactic Immunoglobulin, Vaccinations May Reduce Infections in Hematologic Malignancies

August 13th 2022, 11:30am


Three approaches—prophylactic immunoglobin, antibiotics, and vaccinations—were investigated for their effectiveness at infection prevention in 3 hematological malignancies.

Dr Susan Escudier Reviews Value-Based Payment Programs in Cancer Care

August 9th 2022, 1:17pm


There are some similarities among various value-based payment programs for cancer care, but they are not identical, said Susan Escudier, MD, FACP, vice president, value-based care and quality programs, Texas Oncology.

Mental Health Disorders May Negatively Impact Survival in Patients With HL

August 6th 2022, 7:33pm


The study found that patients with Hodgkin lymphoma (HL) were at an increased risk of any mental health disorder, which was associated with worse long-term outcomes.

Patients Identify Efficacy as Biggest Priority for Waldenström's Macroglobulinemia Treatment

August 5th 2022, 11:10pm


The findings can have important implications for shared decision-making between providers and their patients, as well as for future trials of treatments for the disease.